Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

From the most recent Conference Call:
Nasrats coment on Elites NEW unique IR ADF opioid

Quote:
Can you share any details on the unique abuse deterrent formulations without SequestOx’s of Naltrexone that was included in the pilot study?

No, except to say, I am extremely excited about this formulation because it also is a platform that apply to all the IRs and it happened to be about maybe 10% of the cost. So we're extremely excited about this, but it's still too early in the next few months. Once Dr. Smith files a patent and we do a little more trials, we’ll update a little more about it.